Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
12.7M
-
Number of holders
-
70
-
Total 13F shares, excl. options
-
4.73M
-
Shares change
-
-51K
-
Total reported value, excl. options
-
$159M
-
Value change
-
-$1.69M
-
Number of buys
-
36
-
Number of sells
-
-25
-
Price
-
$33.59
Significant Holders of IRADIMED CORP - Common Stock (IRMD) as of Q3 2021
73 filings reported holding IRMD - IRADIMED CORP - Common Stock as of Q3 2021.
IRADIMED CORP - Common Stock (IRMD) has 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.73M shares
of 12.7M outstanding shares and own 37.11% of the company stock.
Largest 10 shareholders include Nine Ten Capital Management LLC (762K shares), RENAISSANCE TECHNOLOGIES LLC (703K shares), Soleus Capital Management, L.P. (451K shares), BlackRock Inc. (417K shares), VANGUARD GROUP INC (405K shares), Ranger Investment Management, L.P. (218K shares), Russell Investments Group, Ltd. (186K shares), RK Capital Management, LLC (147K shares), Mondrian Investment Partners LTD (137K shares), and RICE HALL JAMES & ASSOCIATES, LLC (120K shares).
This table shows the top 70 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.